Trulieve Cannabis Corp. (TSE:TRU – Free Report) – Analysts at Cormark lowered their FY2026 EPS estimates for shares of Trulieve Cannabis in a research note issued on Thursday, May 8th. Cormark analyst J. Pytlak now expects that the company will post earnings per share of $0.08 for the year, down from their previous estimate of $0.11. Cormark has a “Moderate Buy” rating on the stock.
Several other research firms have also issued reports on TRU. Roth Capital upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a report on Monday, March 3rd. Craig Hallum raised shares of Trulieve Cannabis to a “strong-buy” rating in a research report on Wednesday, February 26th.
Trulieve Cannabis Price Performance
Trulieve Cannabis Company Profile
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Further Reading
- Five stocks we like better than Trulieve Cannabis
- How to Use the MarketBeat Dividend Calculator
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.